TLR7 hyperactivity plays a major role in SLE development, including as monogenic B cell-intrinsic gain-of-function somatic mutations58, and in the activation of naïve and DN2 B cells, which leads to the generation of pathogenic ASC through extrafollicular pathway8. This evidence concerns the gene TLR7 and systemic lupus erythematosus.